MyFinsight
Home
Blog
About
Back
Income Statement
CNS Pharmaceuticals, Inc. (CNSP)
CNS Pharmaceuticals, Inc. (CNSP)
source: myfinsight.com
Interest income
$116,000
(200.45%↑ Y/Y)
Net loss
-$2,588,000
(-8.97%↓ Y/Y)
Total other income
(expense)
$112,000
(225.35%↑ Y/Y)
Interest expense
$4,000
(-4.42%↓ Y/Y)
Loss from operations
-$2,700,000
(-12.06%↓ Y/Y)
Total operating
expenses
$2,700,000
(12.06%↑ Y/Y)
General and
administrative
$1,499,000
(20.66%↑ Y/Y)
Research and development
$1,201,000
(2.91%↑ Y/Y)
Back